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Abstract Background Endoscopic submucosal dissection (ESD) is currently considered the minimal 
invasive endoscopic treatment for early gastric cancer. Most superficial gastric neoplastic lesions 
are depressed type ”0-IIc” (70-80%), while totally flat, classified as type ”0-IIb” early gastric cancer, 
is rarely reported (0.4%). The aim of the present study was to assess the efficacy of narrow band 
imaging (NBI) magnification endoscopy in identifying type “0-IIb” early gastric cancer and ESD 
treatment with curative intention.
Methods Twelve of 615 (2%) patients (10 males, median 72 years), treated by ESD at our center, 
were diagnosed as type “0-IIb” gastric cancer. Ten had exclusively type “0-IIb”, while two had 
combined types “0-IIb+IIc” and “0-IIa+IIb” gastric cancer. Initial diagnosis was made during 
screening gastroscopy, while NBI magnification endoscopy combined with indigo-carmine 
chromoendoscopy were also used.
Results White light endoscopy showed only superficial redness. One patient with signet-ring 
carcinoma showed whitish appearance. Indigo-carmine chromoendoscopy showed better 
visualization, while NBI magnification endoscopy revealed abnormal mucosal microsurface 
and microvascular findings which enabled border marking. ESD with curative intention was 
completed without complications. Histological examination showed complete (R0) resection, 
in 10  patients (83%). One patient with positive margins received additional surgery (8%). 
Mean procedure time was 149 (range 60-190) min. One to six years post-ESD all patients 
remain alive.
Conclusions ESD is considered a safe and effective curative treatment for type “0-IIb” gastric 
cancer, resulting in long-term disease-free survival. NBI magnification endoscopy is effective for 
accurate optical identification and border marking of type “0-IIb” early gastric cancer.
Keywords Endoscopic submucosal dissection, narrow band imaging magnification endoscopy, 
type “0-IIb” early gastric cancer
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Introduction
Endoscopic submucosal dissection (ESD), developed by 
Japanese investigators [1-4], has been successfully used for 
local, minimal invasive treatment of early gastric cancer and is 
considered the treatment of choice for en bloc resection [5-9]. 
Although most superficial neoplastic lesions in the stomach are 
depressed type “0-IIc” (70-80%), totally flat early gastric cancer, 
classified as type “0-IIb” is scarcely reported (9/2098, 0.4% in 
Paris classification [10]), because it is usually missed during 
routine endoscopy and misdiagnosed as chronic gastritis [1,10].
Accurate endoscopic diagnosis and precise evaluation of 
type “0-IIb” early gastric cancer, a fundamental prerequisite for 
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endoscopic treatment, became often difficult or even impossible 
by standard endoscopic techniques [7,11,12]. In these cases, 
high suspicion from endoscopist’s part, in combination with 
incorporation of new technologies in clinical practice may 
increase the diagnostic yield of early gastric cancer [11-13].
Narrow band imaging (NBI) magnification endoscopy 
is a relatively new imaging technique that enhances mucosal 
microsurface structures and microvasculature by using a short 
wavelength and narrow bandwidth illumination (415  nm), 
which has a high affinity to be absorbed by hemoglobin [11-15].
NBI magnification allows more detailed observation of 
mucosal architecture and improves the diagnostic capability 
for determining tumor margins, absolutely necessary for 
curable ESD [7,11-14,16,17]. According to several reports, 
including a recent multicenter study from Japan [7], NBI 
magnification improved the optical identification of early 
gastric cancer compared with conventional endoscopic 
methods [7,12,13,18-23].
In high-risk patients, every erythematous, gastritis-like 
lesion of the stomach should be meticulously evaluated using 
NBI magnification for abnormal microvascular and mucosal 
microsurface findings, corresponding to early gastric cancer 
type “0-IIb”.
Endoscopic therapies became even more important for 
elderly patients, often poor candidates for surgery due to 
comorbidities [24,25]. Complete specimen for histopathology 
is also obtained by ESD. Horizontal and lateral margins of 
the endoscopic specimen, as well as lymphovascular invasion 
should be negative for curative (R0) resection of early gastric 
cancer according to the Japanese classification of gastric 
cancer (JCGC) [22,23]. Overlooked lateral spreading, type 
“0-IIb” gastric cancer be resulted in histologically incomplete 
endoscopic resection [11,12].
The novelty of this paper is that, although endoscopic 
diagnosis and treatment of early gastric cancer is widely 
reported, these reports mainly referred to slightly depressed 
or slightly elevated gastric lesions, classified as type “0-I”, 
“0-IIc”, or “0-IIa” lesions, while international experience of NBI 
magnification endoscopy and ESD in gastritis-like, totally flat, 
type “0-IIb” gastric cancer is limited [26-31].
The aim of the present study was to assess the efficacy of 
endoscopic identification using NBI magnification endoscopy 
and ESD treatment with curative (R0) intention of type 
“0-IIb” early gastric cancer. Secondary endpoint was to access 
the efficacy of endoscopic diagnosis and ESD treatment of 
undifferentiated, type “0-IIb”, signet-ring cell early gastric 
cancer, which belongs to the extended criteria for ESD.
Patients and methods
From 2005 to 2011, a total of 615 patients with endoscopically 
and histologically proven early gastric cancer according to 
JCGC [22] were selected and treated by ESD in the Digestive 
Disease Center of Showa University, Northern Yokohama 
Hospital, Japan. Initial diagnosis was done during screening 
gastroscopy, while definite decision for ESD was made by an 
experienced endoscopist, based on endoscopic macroscopic 
and NBI magnification findings, according to Japanese Gastric 
Cancer Association (JCGA) guidelines [32,33].
The study was approved by the Institutional Review Board 
of the Showa University, Northern Yokohama Hospital. The 
study protocol was explained to the patients before written 
informed consent was obtained. This study was registered with 
the University Hospital Medical Information Network in Japan.
Twelve of 615  (2%) patients, 10  males, mean age 
69±10.1  years, median age 72  years, age range 52-85  years, 
were diagnosed as type “0-IIb” early gastric cancer, according 
to JCGC [22] and Paris endoscopic classification of early 
gastrointestinal (GI) neoplasia [10]. Ten patients had purely 
type “0-IIb” lesions (Fig. 1-5), while two patients had combined 
types “0-IIb+IIc” (Fig. 6) and “0-IIa+IIb” lesions, respectively 
(JCGC) [22]. The patient with type “0-IIb+IIc” early gastric 
cancer had local recurrence after previous ESD. Clinico-
pathological features of patients are shown in Table 1.
The procedures were performed by 7 skilled endoscopists 
under conscious sedation at the Endoscopy department 
in 9 (75%) patients, while 3 (25%) patients were treated 
under general anesthesia with intratracheal intubation. 
CO2 insufflation was available during procedures to avoid 
pneumoperitoneum. All patients were treated at a left lateral 
position.
Figure 1 Type “0-IIb” gastric cancer at the middle gastric body to 
lesser curvature. (A) White light endoscopy except for slight redness 
is almost normal. (B) Indigo-carmine delineates better the lesion. 
(C) Narrow band imaging (NBI) low magnification shows brownish 
area and demarcation line. (D) NBI high magnification shows 
abnormal fine network pattern. (E) NBI high magnification after 
acetic acid spray shows abnormal small pit pattern. (F) Endoscopic 
submucosal dissection ulcer
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A diagnostic gastroscopy was performed just before ESD, 
in order to re-evaluate the gastric lesion and mark the tumor 
borders. A high-resolution NBI magnification endoscope was 
used for marking. A small black hood was mounted on the tip 
of the endoscope to facilitate NBI.
NBI magnification supplied useful information of the 
mucosal pattern in all patients by enhancing mucosal 
microsurface and microvascular architecture, in accordance 
to previous reports [7,11-14,16,17]. A  particular difficulty 
in identification the demarcation line was experienced with 
type “0-IIb” gastric cancers due to the nature of these totally 
flat gastric lesions. The abnormal NBI findings under high 
magnification were further classified according to previous 
report by Yokoyama et al [13]. This classification was extremely 
helpful in predicting the possible differentiation type (Table 3). 
In cases with mixed NBI magnification findings the major 
pattern was described.
NBI magnification imaging after acetic acid spray, 
additionally used upon indication, showed further specific 
abnormal microsurface structural findings, according to 
previous classification [34].
After thorough endoscopic examination, marking of 
the tumor borders was carried out, mainly based on NBI 
magnification findings. Dots were placed outside the 
demarcation line, according to the report by Yao et al [11] 
(Fig. 2, 3, 6 E).
ESD procedure was performed using a therapeutic 
endoscope. Circumferential mucosal incision and direct 
submucosal dissection were carried out with one of the 
specified knives until complete excision was achieved. Flush 
knife (Fujinon Corp., Omiya, Japan) and Triangle Tip Knife 
(TT-Knife) (Olympus Corp. Japan) were the main knives used, 
while a rotable Hook-Knife (Olympus Corp. Japan) was used 
in combination with flush knife in one patient (Table 2). Flush 
Knife (Fujinon Corp., Omiya, Japan), the most commonly used 
knife in 67% of cases, had the advantage of water injection 
through the knife tip to submucosal area during dissection [35].
Endoscopic hemostasis was achieved either with the knife 
used for the dissection or with hemostatic forceps (Coagrasper, 
Olympus Corp.) whenever active bleeding was noticed. 
Hemoclips were not used in this study.
High frequency generators (ERBE corp. Tubingen, 
Germany, 200ICC or V/O 300D) were used for marking, 
circumferential mucosal incision, submucosal dissection, and 
endoscopic hemostasis. Electrosurgical settings were selected 
according to the standard preferences and to guidelines 
provided by the manufacturers.
Individualized strategy was followed during ESD procedure 
according to location and size of the tumor. Typical sequences 
followed in all cases: a) peripheral marking; b) submucosal 
injection to lift the mucosal lesion and inflate the submucosal 
layer; c) peripheral incision; and d) submucosal dissection with 
Figure 3 Type “0-IIb” gastric cancer at the gastric angulus. 
(A) White light endoscopy shows slight redness. (B) Indigo-
carmine chromoendoscopy delineates better the lesion. (C) Narrow 
band imaging (NBI) low magnification shows brownish area with 
demarcation from the surrounding normal mucosa. (D) NBI high 
magnification shows abnormal microsurface pattern with clear 
demarcation line. (E) Tumor border marking with dots just outside the 
demarcation line. (F) Endoscopic submucosal dissection ulcer
Figure 2 Type “0-IIb” gastric cancer at the posterior wall of the middle 
body. (A) and (B) White light endoscopy with low (A) and high (B) 
magnification shows slight flat redness. (C) Crystal violet staining 
shows better delineation of the lesion. (D) Narrow band imaging (NBI) 
magnification shows abnormal microsurface structure, clearly brownish 
area from the surrounding mucosa and demarcation line. (E) Tumor 
border marking with dots outside the demarcation line as evaluated by 
NBI magnification. (F) Endoscopic submucosal dissection ulcer
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simultaneous hemostasis when needed. A 21-25-G injection 
needle was used for submucosal injection.
The location of the lesions was determined according to 
JCGC [22] as upper, middle, lower part, lesser curvature, 
greater curvature, anterior and posterior gastric wall (Table 1). 
Lesions were classified according to the largest diameter as 
≤20  mm (7  patients, 58%) and >20  mm (5  patients, 42%). 
“Procedure time” was defined as the time from insertion of the 
endoscope to complete removal (Table 1).
Fixation of all specimens as well as final histopathological 
examination was performed according to JCGC guidelines [22]. 
Main pathological criteria assessed were histological type [well 
differentiated (tub-1); moderately differentiated (tub-2); or 
poorly differentiated (por)], invasion depth [horizontal (H) and 
vertical (V) margins], and presence or absence of lymphatic or 
vascular invasion.
R0 en bloc resection was defined as a lesion resected in a 
single piece with at least 1  mm of deep and lateral margins 
free of tumor and no lymphatic or vascular invasion. Final 
pathological classification included pT1a [mucosal (M) and/
or upper submucosal (Sm1) cancer] corresponding to ‘R0’ 
resection, and T1b2 (Sm2 for invasive deep submucosal 
cancers), defined as incomplete resection according to TNM 
classification of JCGC [22].
Data is presented as mean ± SD, median and range. 
Statistical significance was evaluated by using the chi-square 
test as needed. P values ≤0.05 were considered as significant.
Results
In the present study conventional white light endoscopy 
(WLE) was unable to show specific characteristics of type 
”0-IIb” early gastric cancer, while in most cases a slightly 
erythematous, “gastritis-like” lesion was detected, difficult 
or even impossible to be distinguished from chronic 
inflammation (Fig.  1-4A, 6A). In one patient with 10x9 mm 
type “0-IIb” signet-ring gastric carcinoma, WLE showed a 
whitish appearance (Fig. 5A).
Better visualization was obtained by indigo-carmine 
chromoendoscopy in 8 of 12 (67%) patients (Fig. 1B, 3-5B), while 
it was totally normal in 4  patients (33%). Chromoendoscopy 
was particularly useful for delineation of combined lesions, 
especially for identifying the elevated element of type 
“0-IIa+IIb” or the depressed element of type “0-IIc+IIb” gastric 
cancer (Fig. 6C). However, tumor margins were unclear in most 
Figure 5 Type “0-IIb” early gastric signet-ring carcinoma measuring 
10x9 mm. (A) White light endoscopy shows a whitish flat area typical 
for signet-ring carcinoma. (B) Indigo-carmine chromoendoscopy. 
Narrow band imaging with low (C) and high (D) magnification. 
(E) Endoscopic submucosal dissection ulcer 
Figure 4 Type “0-IIb” gastric cancer at the upper gastric body along the 
lesser curvature. (A) White light endoscopy shows slight erythematous 
area. (B) Indigo-carmine chromoendoscopy visualizes better the tumor 
but still with unclear tumor borders. (C) Narrow band imaging (NBI) 
with high magnification shows a demarcation line between irregular 
(cancerous) and regular (noncancerous) mucosa. Background mucosa 
shows regular microvascular (open-loop) and microsurface (tubular) 
patterns, while cancerous mucosa shows irregular microvascular 
(tortuous/branched/bizarre vessels) pattern and absence of obvious 
microsurface pattern. (D) Circumferential marking before endocopic 
submucosal dissection (ESD). Dots were placed at the tumor margins, 
as they identified by NBI magnification imaging. (E) Post-ESD gastric 
ulcer. (F) ESD specimen showing horizontal and vertical (submucosal 
invasion) margins positive for gastric cancer
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patients (8 of 9), with “0-IIb” gastric cancer and tumor border 
marking was impossible based only on chromoendoscopy. 
Particularly, it was not feasible to detect the laterally spreading 
“0-IIb” element of type “0-IIa+IIb” gastric cancer.
NBI magnification endoscopy revealed abnormal findings 
(Fig.  1C-D, 2D, 3C-D, 4C, 5C-D, 6D), particularly irregular 
microvascular and mucosal microsurface pattern, in all 
patients and showed better optical identification of type “0-
IIb” gastric cancer than both WLE and chromoendoscopy. The 
most common major and minor NBI patterns are shown in 
Table 3.
Based on the previous standardized NBI magnification 
classification [13], we found that: inter-lobular loop pattern 
(ILL)-1 (58% of cases) or fine network (17% of cases) (Fig. 1C) 
were the major patterns in tub-1 gastric adenocarcinomas; 
ILL-2  (17%) was the major pattern in tub-2; and ILL-2 
combined with corkscrew pattern was identified in one 
patient with por gastric adenocarcinoma. These results were in 
accordance to the previous report by Yokoyama et al [13].
Moreover, NBI magnification after acetic acid spray further 
demonstrated specific abnormal microstructural patterns and 
was useful in equivocal cases (Table 3). Two main malignant 
NBI magnification patterns were identified after acetic acid 
spray, according to previous classification [34]: a) villous 
pattern (in 33% of cases) with fusion or increased intensity 
of villous structures; and b) small pit pattern (in 8% of cases) 
(Fig. 1E).
Demarcation line was clearly identified in all cases by NBI 
magnification (Fig.  1C, 2-3D, 4C, 5-6D). In combined type 
“0-IIa+IIb” lesion, the type “0-IIb” element was only recognized 
by abnormal NBI magnification findings, while demarcation 
line was detected as a white zone between normal metaplastic 
mucosa and tumorous NBI mucosal pattern. Subsequently, 
margin marking was feasible with dots placed outside the 
demarcation line (Fig. 2-3E, 4D, 6E).
ESD was completed in all patients without severe early or 
late complications and it is considered endoscopically complete. 
However, histological examination of the resected specimens 
showed complete (R0) resection in 10 of 12 (83%) patients, 
according to the strict JCGC criteria [22]. In exclusively type 
“0-IIb” gastric cancer, complete R0 resection was possible in 9 
of 10 patients. 
Table 1 Clinicopathological features of type “0-IIb” early gastric 
cancer. 
N=12 patients Mean±SD (range)
Age, years 69±10.1 (52-85)
Lesion size (mm) 22.6±16.8 (5-58)
ESD specimen size (mm) 41.1±16.9 (26-77)
Gender (male/female) (%) 10/2 (83% male)
Endoscopy department (conscious sedation)
Operation room (intubation)
9 pts 75%
3 pts 25%
Procedure time (min) (total) 149±29.7 (60-190)
Lesion size:
≤20 mm
>20 mm
7 pts (58%)
5 pts (42%)
Tumor location
•	Upper	body
•	Middle	body
•	Lower	body (total)
•	Antrum
•	Angulus
•	2	pts (17%)
•	4	pts (33%)
•	6	pts (50%)
•	4	pts (33%)
•	2	pts (17%)
Tumor location
➢ Anterior wall
➢ Posterior wall
➢ Lesser curvature
➢ Great curvature
➢ 2 pts (17%)
➢ 2 pts (17%)
➢ 7 pts (58%)
➢ 1 pt (8%)
ESD, endoscopic submucosal dissection
Table 2 Endoscopic techniques (n=12)
Instruments used n  (N=12) %
•	Flush	knife 8 (67)
•	TT	knife 4 (33)
•	Hook	knife 1 (8)
•		Combination	of	knives
(Flush knife+ +hook knife) 1 (8)
Hood 12 (100)
Complementary endoscopic procedures
•	Argon plasma coagulation 1 (8)
Figure 6 Combined type “0-IIc+IIb” early gastric cancer. (A, B) 
White light endoscopy shows slightly irregular erythematous area 
in the proximity of a scar from previous endoscopic submucosal 
dissection (ESD). (C) Indigo-carmine chromoendoscopy shows 
slightly better delineation of the tumor. (D) Narrow band imaging 
(NBI) magnification shows clearly irregular NBI microstructure and 
demarcation line. (E, F) Tumor marking and ESD ulcer 
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Horizontal and vertical margins of ESD specimen were 
positive for gastric cancer in one patient with exclusive type 
“0-IIb” gastric cancer (Fig. 4F). The tumor was located at the 
upper gastric part (Fig. 4A,B), tumor size was 27x23 mm and 
NBI findings were suitable for fine network (main pattern) 
and corkscrew (minor pattern). Final histological diagnosis 
was tub-1 adenocarcinoma. Gastric cancer in this patient 
was classified as T1b2 (Sm2 invasive cancer) and he was 
subsequently treated by surgery. During 5-year follow up post-
operation he is alive without local disease or distal metastases.
Horizontal margins were positive for gastric adenoma in 
another patient with combined type “0-IIc+IIb” lesion. No 
additional therapy was necessary, while during the 3-year 
follow up post-ESD he is alive with excellent quality of life 
without local recurrence or systemic disease.
The most common location of the type “0-IIb” early gastric 
cancer was the lower gastric body (50%) and lesser curvature 
(58%), while a less common tumor location was the upper 
gastric body (17%).
Mean tumor size was 22.6±16.8  mm, median 20  mm, 
range 5-58  mm, while in 42% of cases, lesion size was 
greater than 20  mm. Regarding the ESD specimen, mean 
size was 41.1±16.9  mm, ranging between 26-77  mm. 
Clinicopathological features, tumor location, and size are 
presented in Table 1.
In most cases one knife was used to complete the ESD. 
Additional argon plasma coagulation was successfully applied at 
the resection borders in one patient. Total mean procedure time 
was 149±29.7 (range 60-190) min, while no differences were 
found between patients treated at the Endoscopy department 
versus the operation room (170 vs. 150 min, P=NS).
No severe early or late complications were reported, 
particularly no early or late severe bleeding, no perforation 
and no need for repeat endoscopy. All patients recovered 
uneventfully after standard hospitalization in similar cases. 
Overall median inpatient stay was 5 days.
Histological type and tumor infiltration depth are presented 
in Table 4. Histopathology showed a tub-1 adenocarcinoma 
in 8  patients (67%), tub-2 in 3  patients (25%), and poor 
differentiation (signet-ring carcinoma) in 1 patient (8%).
The final histopathological results showed mucosal cancer 
(M) in 11 patients (92%) (T1a), while 1 patient (8%) had deep 
submucosal invasion (sm2, T1b2). Lymphovascular or venous 
invasion was not found.
Regarding the type “0-IIb” gastric signet-ring carcinoma, 
histological examination of the 46x39  mm ESD specimen 
showed a 10x9 mm M (T1a) cancer, without lymphovascular 
invasion [ly (-), v (-)] and with both horizontal and lateral 
margins negative (complete R0 resection). No other treatment 
was administered while the patient is still alive 3 years post-
ESD, without local recurrence or distal metastases with 
excellent quality of life.
Finally, no additional therapy was necessary. To date, 
1-6  years post-ESD, all patients remain alive with excellent 
quality of life and without local recurrence or systemic disease.
Discussion
Early gastric cancer usually appears as small depressed or 
slightly elevated area, while totally flat, type “0-IIb” gastric cancer 
Table 4 Histopathological findings of type “0-IIb” early gastric 
cancer (n=12)
n  (%)
Marginal tumor invasion
•	LM (+)	for	cancer
•	LM (+)	for	adenoma
•	VM (+)	for	cancer
•	Ly (+)
•	v (+)
•	cUL(+)
1 (8)
1 (8)
1 (8)
0 (0)
0 (0)
1 (8) (IIb+IIc)
Classification (JCGC [23] and 
Paris [10])
Only IIb 10 pts (83)
IIb+IIc 1 pt}17%IIa+IIb 1pt
Histology
 Mucosal
 Sm2
11 (92)
1 (8)
Outcome of patients with LM(+)
 Operation post-ESD
 Follow up only (LM+for adenoma)
1pt (8) No lymph node 
metastases
1 pt (8) No recurrence
Differentiation
 Well differentiated (tub 1)
 Moderately differentiated (tub 2)
 Poorly differentiated (por) 
8 (67)
3 (25)
1 (8) signet-ring cell 
carcinoma
LM, lateral margin; VM, vertical margin; Ly, lymphovascular invasion; 
v, venous invasion; pUL, pathological ulceration; cUL, endoscopic ulceration; 
Sm2, deep submucosal invasion
Table 3 NBI magnification endoscopic characteristics of type “0-IIb” 
gastric cancer (n=12)
n  (%)
Major NBI pattern
•	ILL1
•	ILL2
•	Fine	network
•	Network-like
7 (58)
2 (17)
2 (17)
1 (8)
Minor NBI pattern
•	ILL-1
•	Corkscrew
•	Network-like
•	No	minor	pattern
2 (17)
3 (25)
1 (8)
6 (50)
NBI after acetic acid spray (major pattern)
•	Villous	pattern
•	Small	pit	pattern
•	Unknown
4 (33)
1 (8)
7 (59)
NBI after acetic acid spray (minor pattern)
•	Villous pattern
•	Small Pit pattern
•	Unknown
1 (8)
2 (17)
9 (75)
NBI, narrow band imaging; ILL1, intra-lobular loop pattern 1; 
ILL2, intra-lobular loop pattern 2 
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consists a relatively rare disease [10]. Only 2% of patients who 
underwent ESD for early gastric cancer during the last decade 
in Digestive Disease Center were finally classified as having type 
“0-IIb” lesions, while exclusively type ‘0-IIb’ gastric cancer was 
even rarer (1.6%). In the Paris endoscopic classification [10] 
the totally flat early gastric cancer, classified as type “0-IIb”, was 
reported in 9 of the 2098 patients (0.4%), while in other studies 
type “0-IIb” early gastric cancer was diagnosed in up to 8.7% 
of cases [26]. However, the frequency of “gastritis-like” early 
gastric cancer is higher (22/50, 44%) after Helicobacter pylori 
eradication, according to a small study [28].
Totally flat gastric cancer can be missed, not only by 
standard WLE but also by chromoendoscopy [7,36], because 
it usually appears as a non-specific, slightly erythematous 
mucosal lesion, resembling gastric erosion or inflammation, as 
it was also the case in the present study (Fig. 1-4A, 6A).
Better visualization is obtained by chromoendoscopy. 
However in 33% of our cases, type “0-IIb” gastric cancer was 
completely undetected after chromoendoscopy, while precise 
identification of the tumor borders was still difficult in most 
cases. Precise tumor border marking was impossible based 
only on chromoendoscopy.
While in elevated type “0-IIa” or depressed type “0-IIc” 
(Fig.  6C) gastric cancers chromoendoscopy effectively 
delineates the tumor margins, in totally flat “0-IIb” lesions, 
tumor borders are usually unclear. The difficulty in diagnosis 
may be one of the causes of the low incidence of type “0-IIb” 
early gastric cancer [2,7,37].
NBI magnification endoscopy showed better optical 
identification of type “0-IIb” gastric cancer than conventional 
endoscopic methods, also in accordance with previous 
reports [7,11-13,38]. Not only was the “0-IIb” gastric cancer 
identified but also the differentiation type could be predicted 
on the basis of specific NBI magnification mucosal and 
microvascular patterns [11-13,38].
Our findings also confirm a previous report regarding the 
4-grade classification of NBI magnification findings in relation 
to gastric cancer differentiation [13]. Particularly, fine network 
and ILL-1 pattern were found in tub-1 adenocarcinomas, 
ILL-2 pattern in tub-2, while combined ILL-2 with corkscrew 
patterns were found in por gastric carcinoma.
Another interesting finding is the usefulness of acetic acid 
spray in equivocal cases, which emphasized the superficial 
glandular structure and enabled enhancement of endoscopic 
tissue characterization under NBI magnification. After acetic 
acid spray two main NBI magnification patterns were identified 
according to previous classification [34], which correspond 
well to the standard NBI patterns described previously [13]. 
The small pit pattern (Fig.  1A) corresponded to the fine 
network pattern, while villous pattern with fusion or increased 
intensity of villous structures corresponded to ILL-1. These 
findings were extremely helpful in distinguishing malignant 
from metaplastic mucosa.
Identification of demarcation line and precise marking of 
tumor borders, fundamental for complete ESD, was possible 
under NBI magnification endoscopic guidance in all patients 
of the present study. NBI magnification was superior to 
both conventional WLE and chromoendoscopy in clearly 
identifying the demarcation line (Fig.  1C, 2-3D, 4C, 5-6D). 
Margin marking was performed with dots placed outside the 
demarcation line, according to the report by Yao et al [11] 
(Fig. 2-3E, 4D, 6E).
ESD was completed in all patients, irrespective of tumor 
size, location, differentiation and all other clinicopathological 
factors studied. This interesting finding was a consequence of 
successful and accurate preoperative evaluation of “0-IIb” gastric 
cancer, leading to accurate selection of patients for endoscopic 
treatment, according to the expanded criteria of JCGC [22].
Finally, histopathological complete R0 resection was found 
in most of the cases (83%), according to the strict JCGC 
criteria [22], while no additional therapy was necessary in these 
patients. Only one patient (8%) with exclusive “0-IIb” gastric 
cancer, had deep submucosal invasion (sm2, T1b2, JCGC) [22] 
and was subsequently treated by surgery. He is alive, 5 years 
post-operation without local disease or distal metastases. In 
this case, histopathology of ESD specimen provided a definite 
biopsy, leading to final accurate curative treatment decision.
In another patient with combined type “0-IIc+IIb” gastric 
cancer, treated for local recurrence after previous ESD, 
lateral margins were positive for gastric adenoma according 
to JCGC [22], corresponding to low-grade intraepithelial 
neoplasia of the revised Vienna classification of epithelial GI 
neoplasia [23]. In this case, however, no additional therapy was 
administered and during the 3-year follow up post-, the patient 
is alive with excellent quality of life, without local recurrence 
or systemic disease.
Although por gastric adenocarcinomas are contraindicated 
for endoscopic treatment due to aggressive behavior and there 
are only relative indications according to expanded criteria for 
ESD (JCGC) [22], in our study curative ESD was successfully 
completed in a patient with type “0-IIb”, signet-ring gastric 
carcinoma, 10x9  mm in diameter (Fig.  5A-E). In this case, 
WLE showed a whitish appearance of the lesion, diagnostic for 
signet-ring gastric carcinoma (Fig. 5A). No other additional 
treatments were necessary, while the patient remained 
alive without local recurrence or distal metastases and with 
excellent quality of life, during the 3-year follow up post-ESD.
Laterally spreading early gastric tumors may 
result in incomplete endoscopic resection and precise 
identification before treatment planning is of significant 
importance [11,14,27,31,39]. This situation was experienced 
in a case with combined type “0-IIa+IIb” early gastric cancer, 
published previously [31], where a very small “0-IIb” laterally 
spreading gastric cancer was identified on basis of abnormal 
NBI magnification findings. Complete R0 en bloc ESD of 
both tumors followed based on border marking under NBI 
magnification guidance [31].
In the latter case, identification of the laterally spreading 
“0-IIb” early gastric cancer was missed by standard endoscopic 
practices and was detected only by NBI magnification, as it 
was also reported by other studies [11]. Accurate pre-ESD 
evaluation is extremely important for optional, curative 
outcome and prevention of late recurrence [40]. Overlooked 
gastric lesions could be one of the possible etiologies of late 
recurrence after ESD for early gastric cancer however further 
studies are necessary [41,42].
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Synchronous multiple or multifocal gastric cancers have 
been already reported in the literature, while synchronous or 
metachronous gastric cancer after initial endoscopic treatment 
was found in 4% and 3.3% of patients respectively, within one 
year after treatment [6,41-45]. In our study no local recurrence 
or systemic disease was reported during 1-6 years of follow up 
post-ESD, while all patients remain alive.
In conclusion, NBI magnification was superior to 
conventional endoscopic methods, not only in providing 
accurate and reliable real-time optical identification of 
pure as well as combined type “0-IIb” early gastric cancer 
or determining the tumor borders, but also in predicting 
possible tumor differentiation, and the feasibility of complete 
endoscopic resection.
The novelty of the present study is that, although ESD for 
early gastric cancer is widely reported [5-9], these reports 
mainly referred to slightly depressed or slightly elevated 
gastric lesions, classified as type “0-I”, “0-IIc”, or “0-IIa” 
lesions, while international experience of ESD in gastritis-
like, totally flat, type “0-IIb” gastric cancer is limited. Our 
study have demonstrated, that successful curative R0 ESD was 
feasible in the majority of cases (83%) with type “0-IIb” early 
gastric cancer, resulting in long-term disease-free survival 
with excellent quality of life.
Even in one case of undifferentiated, type “0-IIb”, 
signet-ring cell gastric carcinoma, a relative indication for 
ESD, accurate endoscopic diagnosis by NBI magnification 
followed by curative R0 ESD resection was successfully 
completed.
Although the number of our patients was low, the rarity 
of type “0-IIb” early gastric cancer in combination with the 
successful outcome after ESD, in these diagnostically and 
therapeutically difficult cases, made our study interesting. 
However, larger multicenter studies are warranted.
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